Haemophilia A
Clinical trials for Haemophilia A explained in plain language.
Never miss a new study
Get alerted when new Haemophilia A trials appear
Sign up with your email to follow new studies for Haemophilia A, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a daily pill replace needles for hemophilia a?
Disease control Recruiting nowThis study tests an experimental oral medicine called Inno8 in 30 adults with hemophilia A. The goal is to see if it is safe and how the body processes it. Participants will take multiple doses over about 11 weeks. If successful, Inno8 could offer a more convenient way to control…
Matched conditions: HAEMOPHILIA A
Phase 1 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New hope for haemophilia a patients: immune tolerance induction may eliminate clotting factor blockers
Disease control Recruiting nowThis study looks at whether a treatment called immune tolerance induction (ITI) can help people with haemophilia A who have developed inhibitors—antibodies that block standard clotting factor therapy. Researchers will give high doses of individualized factor VIII concentrates to …
Matched conditions: HAEMOPHILIA A
Sponsor: Haemophilia Centre Rhine Main • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for kids with hemophilia: can SCT800 stop bleeds before they start?
Disease control Recruiting nowThis study is testing a drug called SCT800, a lab-made clotting factor, to prevent bleeding episodes in 36 boys with severe hemophilia A who have never been treated before. Participants receive regular infusions of SCT800, and researchers will monitor how many bleeding events occ…
Matched conditions: HAEMOPHILIA A
Phase 3 • Sponsor: Sinocelltech Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Can an ultra-long-acting factor VIII simplify surgery for hemophilia a patients?
Knowledge-focused Recruiting nowThis study collects real-world data on how hemophilia A patients are managed during and after surgery when using efanesoctocog alfa (Altuvoct), a long-acting clotting factor. Researchers will track how much of the drug is needed, how often it is given, and how long patients stay …
Matched conditions: HAEMOPHILIA A
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Hemophilia a study observes how new patients respond to factor VIII in daily practice
Knowledge-focused Recruiting nowThis study is observing how well three Factor VIII concentrates (Nuwiq, Octanate, Wilate) work in real-world settings for people with severe hemophilia A who have had little or no prior treatment. Researchers will track bleeding rates and side effects in about 200 participants of…
Matched conditions: HAEMOPHILIA A
Sponsor: Octapharma • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC